Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Dow
Harvard Business School
Fuji
Express Scripts
Daiichi Sankyo
US Department of Justice
Medtronic

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020452

« Back to Dashboard

NDA 020452 describes PARAPLATIN, which is a drug marketed by Corden Pharma and Cordenpharma and is included in two NDAs. Additional details are available on the PARAPLATIN profile page.

The generic ingredient in PARAPLATIN is carboplatin. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the carboplatin profile page.
Summary for 020452
Tradename:PARAPLATIN
Applicant:Cordenpharma
Ingredient:carboplatin
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020452

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;IV (INFUSION)Strength50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 14, 2003TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;IV (INFUSION)Strength150MG/15ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 14, 2003TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;IV (INFUSION)Strength450MG/45ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 14, 2003TE:RLD:Yes

Expired US Patents for NDA 020452

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-003 Jul 14, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-004 Jan 15, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-001 Jul 14, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-002 Jul 14, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
UBS
Cipla
Cerilliant
Fuji
Queensland Health
Chinese Patent Office
Deloitte
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.